The invention relates to a group of novel phenylpiperazine derivatives with a dual mode of action: serotonin reuptake inhibition and partial agonism on dopamine-D
2
receptors. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect.
The compounds have the general formula (1):
wherein the symbols have the meanings given in the specification.
本发明涉及一组新型苯基
哌嗪衍
生物,具有双重作用模式:抑制5-羟
色胺再摄取和部分激动
多巴胺D2受体。本发明还涉及使用本文所披露的化合物制造具有有益效果的药物。这些化合物的通式为(1):其中符号具有规范中所给出的含义。